Aurum Institute
Aurum Institute
Explore linked clinical trials.4 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Structured Peer-delivered ART and Reentry Community Strategy | Retention in Care | Recruiting | Not applicable | 2026-06-02 | NCT06027671 | |
| First-in-Human Trial of the Novel Tuberculosis Vaccine Candidate, H107e/CAF®10b | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, tuberculosis | Active, not recruiting | Phase 1 | 2026-03-10 | NCT06050356 | |
| Periodic Presumptive Treatment vs. doxyPEP for STI Control in Kenyan MSM | Bacterial Infections and Mycoses, Genital Diseases, Infections, Neisseriaceae Infections, Treponema infectious disease, Urogenital Diseases, bacterial infectious disease, bacterial sexually transmitted disease, chlamydia infectious disease, chlamydiaceae infections, gonorrhea, gram-negative bacterial infections, infectious disease, sexually transmitted disease, spirochaetales infections, syphilis | Recruiting | Phase 4 | 2025-11-19 | NCT06468462 | |
| Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial) | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, tuberculosis | Not yet recruiting | Phase 3 | 2025-09-09 | NCT07163143 |